Bad-Smelling Mucus in the Nose While Taking Wegovy

What Wegovy's trial data and prescribing information actually say about nasal symptoms

The STEP 1 trial, published in the New England Journal of Medicine, enrolled nearly 2,000 adults with obesity over 68 weeks and documented side effects in detail. Gastrointestinal effects dominated (nausea, vomiting, diarrhoea, constipation) as they do across GLP-1 medicines. Nasal or sinus odour wasn't flagged as a treatment-emergent event in that dataset. The NHS semaglutide medicines page similarly does not list altered nasal mucus smell among known side effects. That matters, because it tells us this isn't a pharmacological effect the regulatory evidence identified at scale. What it doesn't tell us is that individual patients aren't noticing something real. Post-marketing experience routinely surfaces sensory changes that large trials, by design, aren't powered to detect. Taste changes (food tasting metallic, blander, or different) have been reported informally across GLP-1 users, and smell and taste are tightly linked. If you want a thorough breakdown of what patients actually report, our page on whether Wegovy can cause nose bleeds and other nasal symptoms covers the wider picture of upper airway changes in detail. The absence of a formal signal is reassuring; it isn't the same as a clean bill of evidence that nothing is happening.

Hydration, mucus concentration, and why Wegovy's appetite effects matter here

One of Wegovy's most consistent effects is appetite reduction. People eat less, sometimes significantly less, and in the early weeks of treatment many patients also drink less simply because the drive to consume anything (food or fluid) is blunted. Mild, subclinical dehydration can alter the character of mucus throughout the body: it becomes more concentrated, tackier, and can develop a stronger odour because the proteins and compounds within it are less diluted. This is a physiological fact entirely independent of semaglutide's mechanism; it applies to anyone who isn't drinking enough. The practical fix is deliberate, consistent water intake even when you don't feel thirsty. Our Wegovy treatment guide covers how to support your body through the early adjustment period. The 30-minute fasting window required for the Wegovy tablet formulation (first thing in the morning before the kettle goes on) is one example of how oral semaglutide alters morning routines; similar mindfulness about fluid habits applies to the injection too.

Could GLP-1 receptors in nasal tissue explain sensory changes?

GLP-1 receptors are distributed more widely in the body than the gut alone. Research has identified them in the brain, heart, kidneys, and in cells of the upper respiratory tract. Whether semaglutide's action at these peripheral receptors is sufficient to change mucus secretion or local inflammatory tone in the nose isn't yet established in clinical literature. Some researchers have explored the role of GLP-1 in modulating mucosal immunity, but that work remains largely preclinical. What's more established is that semaglutide does change oral environment (slower gastric emptying, altered reflux patterns) and changes to post-nasal drip quality or acid exposure in the throat can affect how mucus smells. If you've also noticed a runny nose since starting Wegovy, these symptoms may share a common thread. It's worth noting, too, that any change in smell perception itself (rather than the mucus) can make ordinary nasal secretions seem more pungent than they are, a phenomenon sometimes linked to the altered taste sensitivity patients describe on GLP-1 treatment, something that high-profile users discussed when coverage of stars on Wegovy brought wider public attention to the medicine's less obvious effects. Questions about smell-related changes more broadly are covered on our Wegovy and smell changes page.

When to take nasal symptoms more seriously and what to do

Bad-smelling mucus that appears briefly and resolves is unlikely to be a concern specific to Wegovy. If it comes alongside other symptoms (facial pain or pressure, thick discoloured discharge, fever, or a persistent blocked nose) a sinus infection or other ENT condition is a more probable explanation than the medicine itself, and your GP is the right first call. Semaglutide does not increase susceptibility to sinus infections in its established evidence base. That said, if you notice any new symptom that troubles you while on a prescription medicine, report it. The MHRA's Yellow Card scheme exists precisely for suspected side effects that patients and clinicians want to flag, even where a causal link is uncertain, individual reports build the post-marketing picture that trials can't fully capture. At nume, a real prescriber reads every patient's case; if something is bothering you between orders, our aftercare team is available seven days a week. You don't need to wait for your next scheduled review to raise a concern. If you are a clinician or business owner rather than a patient, our guidance on selling semaglutide safely and legally sets out the regulatory requirements you need to meet. If you haven't yet started treatment and want to understand whether Wegovy is suitable for your circumstances, you can check your eligibility with a free consultation, a GPhC-registered prescriber reviews every application personally.